enVVeno Medical Corporati... (NVNO)
NASDAQ: NVNO
· Real-Time Price · USD
3.60
-0.05 (-1.37%)
At close: May 12, 2025, 3:59 PM
3.51
-2.50%
After-hours: May 12, 2025, 05:12 PM EDT
enVVeno Medical Revenue Breakdown
Period Ending | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|
Royalty Income Revenue | 31.24K | 116.15K |
Royalty Income Revenue Growth | -73.10% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.4M | 3.46M | 3.31M | 2.49M | 2.31M | 3.16M | 2.55M | 2.6M | 3.2M | 3.66M | 3.66M | 3.91M | 3.78M | 7.21M | 1.48M | 1.3M | 1.18M | 1.88M | 1.16M | 839.74K | 997.9K | 922.34K | 1.16M | 1.53M | 1.3M | 1.22M | 1.1M | 2.91M | 1.25M | 1.66M | 1.66M | 1.09M | 1.05M | 1.23M | 958.83K | 1.22M | 1.22M | 458.09K |
Selling, General, and Administrative Revenue Growth | -30.78% | +4.59% | +32.81% | +7.92% | -26.97% | +23.99% | -1.88% | -18.80% | -12.59% | +0.11% | -6.49% | +3.44% | -47.54% | +386.56% | +14.37% | +10.14% | -37.46% | +61.60% | +38.63% | -15.85% | +8.19% | -20.29% | -24.46% | +17.77% | +6.91% | +10.12% | -62.10% | +133.74% | -24.73% | -0.44% | +53.28% | +3.44% | -14.56% | +28.12% | -21.65% | 0.00% | +167.15% | n/a |
Research and Development Revenue | 2.56M | 3.51M | 2.86M | 2.83M | 3.05M | 2.98M | 2.8M | 4.21M | 3.6M | 2.8M | 2.49M | 3.07M | 1.55M | 1.78M | 1.22M | 1.09M | 1.63M | 2.28M | 758.2K | 706.17K | 510.62K | 787.83K | 676.97K | 428.31K | 313.01K | 293.24K | 424.6K | 280.42K | 240.49K | 349.09K | 43.07K | 184.92K | 72.66K | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | -27.21% | +22.88% | +1.20% | -7.44% | +2.38% | +6.54% | -33.60% | +17.22% | +28.53% | +12.24% | -18.91% | +98.00% | -12.89% | +45.49% | +12.37% | -33.22% | -28.34% | +200.35% | +7.37% | +38.30% | -35.19% | +16.38% | +58.06% | +36.83% | +6.74% | -30.94% | +51.41% | +16.60% | -31.11% | +710.53% | -76.71% | +154.50% | n/a | n/a | n/a | n/a | n/a | n/a |